Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Linoleic acid, glycemic control and Type 2 diabetes
Martha A Belury1, Rachel M Cole2, Deena B Snoke2
1Program of Human Nutrition, 1787 Neil Avenue, 302 Campbell Hall, The Ohio State University, Columbus, OH 43210, USA.
Higher intake of linoleic acid (LA), a fatty acid, is linked to a reduced risk of type 2 diabetes. This finding supports LA
Area of Science:
- Nutrition Science
- Metabolic Health
- Chronic Disease Epidemiology
Background:
- Dietary fat quality influences chronic disease risk, including cardiovascular diseases, cancers, and type 2 diabetes (T2DM).
- Specific fatty acids play a crucial role in metabolic health and disease prevention.
- Previous research indicated potential benefits of linoleic acid (LA) for glycemic control.
Purpose of the Study:
- To review clinical trials investigating the role of linoleic acid (LA) in glycemia.
- To examine the association between LA intake biomarkers and type 2 diabetes (T2DM) risk.
- To evaluate the impact of LA on insulin sensitivity.
Main Methods:
- Pooled analysis of 20 international studies.
- Review of key clinical trials on LA, glycemia, and insulin sensitivity.
- Analysis of linoleic acid (18:2n-6 LA) biomarkers and T2DM incidence.
Main Results:
- Higher linoleic acid (LA) biomarkers show a dose-dependent decrease in type 2 diabetes (T2DM) incidence.
- Biomarkers of LA intake are consistently associated with reduced T2DM risk.
- LA intake is linked to improved glycemic control and insulin sensitivity.
Conclusions:
- Linoleic acid (LA) consumption is associated with a lower risk of developing type 2 diabetes (T2DM).
- Evidence supports LA's beneficial role in managing glycemia and enhancing insulin sensitivity.
- Dietary fatty acid quality, specifically LA intake, is a significant factor in metabolic health.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
10:09Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Nucleic Acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...